Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
about
Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic interventionBiomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapyAssociation of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival.Using serum α-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff?Baseline quantitative hepatitis B core antibody could strongly predict survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study.Gene Signature Associated with Upregulation of the Wnt/β-Catenin Signaling Pathway Predicts Tumor Response to Transarterial Embolization.Risk stratification for locally advanced hepatocellular carcinoma using pretreatment alpha-foetoprotein and 18 F-fluoro-2-deoxyglucose positron emission tomography.Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization.Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation.The status of transarterial chemoembolization treatment in the era of precision oncology.The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.Evaluation of Diagnostic Efficiency of Alpha-Fetoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Single-Center Experience
P2860
Q28080281-72923DC6-FBC1-4041-91CE-CB7EF575B71BQ34256150-CF0CD9E2-0BA3-4ABB-B299-171684335FB6Q34282931-697BA8DF-10C3-4A26-9096-D7F91AF8EBC6Q35148136-27F95B3E-30DA-4784-8C35-7557E58CA89BQ36183134-F2B942B6-CD23-406A-A352-9C866D015950Q37681702-A55285D1-45A4-48B5-9D6D-4F45759311C8Q38996765-C4AD109D-CD54-4077-BD08-72150EAC7F48Q39225076-FF3257D9-C933-44F2-A953-6D733F83BBD3Q41496862-AB9B763E-9E0E-45B4-94C7-09FE46E9B82FQ45385200-AB47DD6B-6DDF-41C7-AACE-2B6CA41CAC33Q46035308-49A2DE25-EE67-42FE-ADCE-5EE12D1DBD45Q49491370-0E193E78-5564-4D13-A776-5174C87027D1Q53027673-6D63FF00-B38B-4C2B-8091-68DE6F8CAFF7Q58552332-22C1A093-9F82-4CC9-98CC-D88BCEC8C1C9
P2860
Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prognostic significance of alp ...... ansarterial chemoembolization.
@en
Prognostic significance of alp ...... ansarterial chemoembolization.
@nl
type
label
Prognostic significance of alp ...... ansarterial chemoembolization.
@en
Prognostic significance of alp ...... ansarterial chemoembolization.
@nl
prefLabel
Prognostic significance of alp ...... ansarterial chemoembolization.
@en
Prognostic significance of alp ...... ansarterial chemoembolization.
@nl
P2093
P2860
P1476
Prognostic significance of alp ...... ansarterial chemoembolization.
@en
P2093
Boheng Zhang
Jinglin Xia
Jubo Zhang
Ningling Ge
Rongxin Chen
Shenglong Ye
Xiaoying Xie
Yanhong Wang
P2860
P2888
P304
P356
10.1245/S10434-012-2368-5
P577
2012-04-25T00:00:00Z
P6179
1044881571